DeviceTalks  By  cover art

DeviceTalks

By: DeviceTalks
  • Summary

  • The DeviceTalks Podcast Network delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies. Explore the DeviceTalks Podcast Network, home to more than 8 podcasts: • AbbottTalks • AI Meets Life Sci • Boston Scientific Talks • DeviceTalks Weekly • IntuitiveTalks • MedtechWOMEN Talks • MedtronicTalks • Ortho Innovation Talks: Zimmer Biomet • StrykerTalks
    All rights reserved
    Show more Show less
Episodes
  • BD’s CTO Beth McCombs Explains How Medtech Innovation Can Deliver Real Help to Patients, Providers
    May 17 2024
    In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD. This is a replay of the opening keynote interview at DeviceTalks Boston. This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.
    Show more Show less
    50 mins
  • Hear the Final Word About DeviceTalks Boston: Live Recording of DeviceTalks Weekly On Stage
    May 3 2024
    In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business. Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com. Please subscribe to the DeviceTalks Podcast Network.
    Show more Show less
    43 mins
  • Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care
    Apr 30 2024
    In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition. Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations. Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage. Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.
    Show more Show less
    43 mins

What listeners say about DeviceTalks

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.